Press release
India Pharmaceutical Excipients Market is Projected to Surpass USD 2032.69 Million By the End of 2030 with a Growing CAGR of 16.31% | Infinium Global Research
To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1349
Inactive Excipients Crucial for Formulation Development
Inactive excipients, playing a pivotal role in formulation development alongside active ingredients, structure a significant portion of dosage forms in pharmaceutical industries. The rise in demand for accessible medication, coupled with the considerable growth of generic drug production in India, is expected to drive the demand for pharmaceutical excipients in the country.
Modernization of Indian Pharmaceutical Industries
To meet Good Manufacturing Practices (GMP) and international standards, the Indian pharmaceutical industry is undergoing rapid modernization and transformation. Large companies are increasingly sourcing excipients from India, considering it an attractive source for commodity or non-functional excipients.
Contract Manufacturing Sector's Steady Rise
India has emerged as a strong pharmaceutical base with a growing contract manufacturing sector, currently expanding at a remarkable rate of 20%. The sector's progress, driven by the presence of multinational pharmaceutical organizations, is fueling the demand for active ingredients and essential excipients such as diluents, fillers, binders, disintegrants, lubricants, coloring agents, and preservatives.
Challenges and Opportunities in Excipient Manufacturing
While India excels in API Manufacturing, stringent regulations pose challenges for excipient manufacturing. The need for new excipients continues to grow, especially with advancements in novel drug delivery systems and biotechnology-derived drugs. The establishment of the International Excipient Council (IPEC) India aims to promote the excipient industry in the country, acting as a knowledge base and resource center.
Global Dominance in Generic Drug Production
India's pharmaceutical industry is recognized as the "pharmacy of the world," contributing to 40% of the United States' generic demand. The country's ability to produce affordable generic drugs positions it as a major player globally. The surge in generic drug production further emphasizes the crucial role of inactive excipients in formulation development.
Contract Manufacturing Opportunities and Challenges
The growing contract manufacturing industry in India presents opportunities for small and medium enterprises (SMEs) to capitalize on the expanding sector. Outsourcing critical processes offers advantages such as cost savings, expertise, speed, flexibility, and the ability to focus on core competencies. The cost advantages, coupled with resources like a skilled workforce and WHO-GMP approved production premises, make India an attractive outsourcing destination.
Compliance Challenges and Development of Novel Excipients
The implementation of guidelines for ascertaining good manufacturing practice for excipients poses initial challenges for compliance. However, this opens doors for the development of novel excipients in the market. The pharmaceutical industry is focusing on multifunctional excipients to enhance solubility, absorption, disintegration, and stability for parenteral formulations.
Opportunities in Novel Drug Delivery Systems
The growing development of novel pharmaceutical excipients presents burgeoning opportunities in the market. Excipients designed to be biologically inactive remove barriers and offer a low-risk solution to the current shortage of new drug formulations. Nanotechnology-enabled and liposomal delivery systems, along with co-processed excipients, are gaining significance in the market.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/1349
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Pharmaceutical Excipients Market Highlights
2.2. Pharmaceutical Excipients Market Projection
2.3. Pharmaceutical Excipients Market Regional Highlights
Chapter 3. Global Pharmaceutical Excipients Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Pharmaceutical Excipients Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Type
3.5.2. IGR-Growth Matrix Analysis by Functionality
3.5.3. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Pharmaceutical Excipients Market
Chapter 4. Pharmaceutical Excipients Market Macro Indicator Analysis
Chapter 5. Global Pharmaceutical Excipients Market by Type
5.1. Organic
5.2. Inorganic
Chapter 6. Global Pharmaceutical Excipients Market by Functionality
6.1. Binders & Fillers
6.2. Coating Agents
6.3. Disintegrants
6.4. Flavoring Agents and Colorants
6.5. Lubricants and Glidants
6.6. Sweeteners
6.7. Preservatives & Antioxidants
6.8. Others
Chapter 7. Global Pharmaceutical Excipients Market by Region 2023-2030
7.1. North America
7.1.1. North America Pharmaceutical Excipients Market by Type
7.1.2. North America Pharmaceutical Excipients Market by Functionality
7.1.3. North America Pharmaceutical Excipients Market by Country
7.2. Europe
7.2.1. Europe Pharmaceutical Excipients Market by Type
7.2.2. Europe Pharmaceutical Excipients Market by Functionality
7.2.3. Europe Pharmaceutical Excipients Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Pharmaceutical Excipients Market by Type
7.3.2. Asia-Pacific Pharmaceutical Excipients Market by Functionality
7.3.3. Asia-Pacific Pharmaceutical Excipients Market by Country
7.4. RoW
7.4.1. RoW Pharmaceutical Excipients Market by Type
7.4.2. RoW Pharmaceutical Excipients Market by Functionality
7.4.3. RoW Pharmaceutical Excipients Market by Sub-region
Chapter 8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Pharmaceutical Excipients Market
8.2. Companies Profiles
8.2.1. BASF SE
8.2.2. Evonik Industries
8.2.3. Ashland Global Holdings Inc.
8.2.4. Dow Chemical Company
8.2.5. Roquette Frères.
8.2.6. Kerry Group PLC
8.2.7. Associated British Foods plc
8.2.8. lubrizol chemical company
8.2.9. Archer-Daniels-Midland Co
8.2.10. Croda Industrial Chemical
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/1349
Reasons to Buy this Report:
=> Comprehensive analysis of regional markets of India pharmaceutical excipients.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release India Pharmaceutical Excipients Market is Projected to Surpass USD 2032.69 Million By the End of 2030 with a Growing CAGR of 16.31% | Infinium Global Research here
News-ID: 3282704 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Excipient
Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Albumin Excipient Market Size Growth Forecast: What to Expect by 2025?
The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of…
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater…
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market…
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197
Market Analysis:
Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical…
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market
Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,…
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027.
The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and…
